Diethylnitrosamine

signal transducer and activator of transcription 3 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34686650 CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis. 2021 Oct 22 2
2 34921636 TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes. 2021 Dec 18 2
3 30474622 The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN). 2018 Nov 26 1
4 27696512 Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma. 2017 Jan 1
5 28401002 Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway. 2017 1
6 30873458 Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1. 2016 Apr 15 2
7 25519169 C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis. 2015 Mar 1
8 22911886 Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine. 2014 Jan 4
9 24476004 Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma. 2014 Aug 2
10 21684247 Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. 2011 Aug 1
11 22136659 STAT3 activation in monocytes accelerates liver cancer progression. 2011 Dec 5 2